Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement.
COVID-19
Cardiac Surgical Procedures
/ methods
Cardiology
/ methods
Coronavirus Infections
/ epidemiology
Cross Infection
/ prevention & control
Female
Heart Diseases
/ diagnostic imaging
Humans
Male
Occupational Health
/ statistics & numerical data
Pandemics
/ prevention & control
Patient Safety
Pneumonia, Viral
/ epidemiology
Practice Guidelines as Topic
Societies, Medical
Triage
/ standards
United States
COVID-19
MitraClip
TAVR
structural heart disease
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
pubmed:
7
4
2020
medline:
2
10
2020
entrez:
7
4
2020
Statut:
ppublish
Résumé
The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment, as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
659-663Informations de copyright
© 2020 by the American College of Cardiology Foundation and Wiley Periodicals, Inc.
Références
Centers for Medicare and Medicaid Services. Non-emergent, elective medical services, and treatment recommendations. https://www.cms.gov/files/document/31820-cms-adult-elective-surgery-and-procedures-recommendations.pdf. Accessed April 7, 2020.
Elbaz-Greener G, Maish S, Fang J, et al. Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement: a population study. Circulation. 2018;138:483-493.
Elbaz-Greener G, Yarranton B, Qiu F, et al. Association between wait time for transcatheter aortic valve replacement and early postprocedural outcomes. J Am Heart Assoc. 2019;8:e010407.
Butala N, Chung M, Secemsky EA, et al. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: variation in practice and outcomes. J Am Coll Cardiol Intv. 2020;75(11 Supplement 1):1428.
Hyman MC, Vemulapalli S, Szeto WY, et al. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: insights from the national ACC/STS TVT registry. Circulation. 2017;136:2132-2140.
Van Mieghem NM, van der Boon RM, Faqiri E, et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. J Am Coll Cardiol Intv. 2013;8:867-875.
Kotronias RA, Kwok CS, George S, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6:e005960.
Guerrero M, Urena M, Himbert D, et al. One-year outcomes of trans-catheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71:1841-1853.
Guerrero M, Vemulapalli S, Xiang K, et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-rings), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States. Circ Cardiovasc Interv. 2020;13:e008425.